ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.
Tumour Sites: Haematological Malignancies
Clinical Practice Guidelines
Latest ESMO videos
Featured medwireNews
Mosunetuzumab offers high response rates in relapsed or refractory follicular lymphoma
Liso-Cel CAR T-Cell Therapy May TRANSFORM Second-Line LBCL Care
Isatuximab Boosts MRD Negativity When Added to Standard Care for Newly Diagnosed Multiple Myeloma
Tisagenlecleucel Fails To Extend Aggressive B-Cell Lymphoma Survival
Axi-Cel Extends Relapsed/Refractory Large B-Cell Lymphoma EFS
E-Learning
ESMO E-Learning: Treatment of Newly Diagnosed Classical Hodgkin Lymphoma
ESMO E-Learning: Open Questions in the Treatment of Follicular Lymphoma
ESMO E-Learning: Treatment of Multiple Myeloma Patients
ESMO E-Learning: Chronic Lymphocytic Leukaemia (CLL): State-of-the-art
ESMO E-Learning: Mantle Cell Lymphoma
Meeting resources
Presentation
Presenter: Christina Yap
Session: How to write a grant
Resources:
Slides
Webcast
Next generation genome editing for enabling allogeneic cell products
Presenter: Qasim Waseem
Session: Cellular therapy beyond CART
Resources:
Slides
Webcast
Bispecific gamma-delta T-cell engagers for the treatment of cancer
Presenter: Hans van der Vliet
Session: Bispecifics and T-cell engagers
Resources:
Slides
Webcast
ESMO Summit Africa 2022
Participant Clinical Case Discussion: lymphoma Hodgkin
Presenter: R. Jassat, ZA
Session: Session 7 - Pregnancy and Fertility preservation in cancer
Resources:
Slides